GoAI
Get started
LifeTech Scientific Corporation logo

LifeTech Scientific Corporation

1302.HK

HKSEHealthcareMedical - Devices

Open in GoAI

Latest quote

HK$1.34

HK$0.00 · 0.00%

Aug 25, 10:34 AM HKT

1302.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Industry
Medical - Devices
Sector
Healthcare
Headquarters
CN

Market position

Day range

Current HK$1.34

52-week range

Current HK$1.34

Open
HK$1.34
Previous close
HK$1.34
Volume
2.52M
Market cap
5.9B HKD
50-day average
HK$1.4337
-6.54% below average
200-day average
HK$1.69
-20.71% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
5.51B CNY
P/E (TTM)
34.81×
P/B (TTM)
1.52×
P/S (TTM)
3.69×
EV / EBITDA
18.89×
Earnings yield
2.36%
Free cash flow yield
7.99%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
74.40%
Operating margin
13.48%
Net margin
10.79%
Return on equity
4.21%
Return on assets
2.95%
Return on invested capital
3.06%

Financial health

Debt / equity
0×
Current ratio
1.57×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends88%60%32%4%Gross margin, FY2021: 80.79%Gross margin, FY2022: 79.64%Gross margin, FY2023: 78.57%Gross margin, FY2024: 75.28%Gross margin, FY2025: 74.40%Operating margin, FY2021: 35.53%Operating margin, FY2022: 34.26%Operating margin, FY2023: 30.25%Operating margin, FY2024: 14.29%Operating margin, FY2025: 13.48%Net margin, FY2021: 31.61%Net margin, FY2022: 29.65%Net margin, FY2023: 20.77%Net margin, FY2024: 17.06%Net margin, FY2025: 10.79%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 80.79%. Gross margin FY2022 79.64%. Gross margin FY2023 78.57%. Gross margin FY2024 75.28%. Gross margin FY2025 74.40%. Operating margin FY2021 35.53%. Operating margin FY2022 34.26%. Operating margin FY2023 30.25%. Operating margin FY2024 14.29%. Operating margin FY2025 13.48%. Net margin FY2021 31.61%. Net margin FY2022 29.65%. Net margin FY2023 20.77%. Net margin FY2024 17.06%. Net margin FY2025 10.79%.

Income trends

Revenue

1.37B CNY+5.07%

Operating income

184.71M CNY-0.87%

Net income

147.83M CNY-33.53%
Income trends across reported periods1.49B CNY1B CNY514.41M CNY25.63M CNYRevenue, FY2021: 925.33M CNYRevenue, FY2022: 1.1B CNYRevenue, FY2023: 1.27B CNYRevenue, FY2024: 1.3B CNYRevenue, FY2025: 1.37B CNYOperating income, FY2021: 328.74M CNYOperating income, FY2022: 375.93M CNYOperating income, FY2023: 383.28M CNYOperating income, FY2024: 186.34M CNYOperating income, FY2025: 184.71M CNYNet income, FY2021: 292.47M CNYNet income, FY2022: 325.34M CNYNet income, FY2023: 263.24M CNYNet income, FY2024: 222.39M CNYNet income, FY2025: 147.83M CNYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 925.33M CNY. Revenue FY2022 1.1B CNY. Revenue FY2023 1.27B CNY. Revenue FY2024 1.3B CNY. Revenue FY2025 1.37B CNY. Operating income FY2021 328.74M CNY. Operating income FY2022 375.93M CNY. Operating income FY2023 383.28M CNY. Operating income FY2024 186.34M CNY. Operating income FY2025 184.71M CNY. Net income FY2021 292.47M CNY. Net income FY2022 325.34M CNY. Net income FY2023 263.24M CNY. Net income FY2024 222.39M CNY. Net income FY2025 147.83M CNY.
Metric (CNY)FY2025FY2024FY2023FY2022FY2021
Revenue1.37B CNY1.3B CNY1.27B CNY1.1B CNY925.33M CNY
Cost of goods sold350.67M CNY322.26M CNY271.54M CNY223.38M CNY177.8M CNY
Gross profit1.02B CNY981.44M CNY995.64M CNY873.93M CNY747.53M CNY
Research and development242.66M CNY302.92M CNY297.92M CNY208.48M CNY145.89M CNY
Selling, general, and administrative608.2M CNY504.2M CNY414.59M CNY347.7M CNY291.18M CNY
Operating expenses834.4M CNY795.1M CNY612.36M CNY497.99M CNY420.86M CNY
Interest income25.46M CNY18.57M CNY12.78M CNY16.65M CNY14.38M CNY
Interest expense210K CNY1.89M CNY722K CNY632K CNY2.61M CNY
Depreciation and amortization96.33M CNY63.5M CNY77.16M CNY67.11M CNY62.05M CNY
Operating income184.71M CNY186.34M CNY383.28M CNY375.93M CNY328.74M CNY
Net income147.83M CNY222.39M CNY263.24M CNY325.34M CNY292.47M CNY

Company facts updated Aug 25, 2026.

Earnings

EPS beat rate
0%
0 beats, 3 misses, 0 met estimates
Average EPS surprise
-36.34%
3 comparable reports
Latest EPS result
0.02

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates0.10.070.030Q3 '22Q1 '23Q3 '23Q1 '24Q3 '24Q1 '25Q3 '25Q1 '26
Q3 2022, reported Aug 30, 2022: actual 0.056, estimate —, surprise —, Comparison unavailable. Q1 2023, reported Mar 29, 2023: actual 0.029, estimate —, surprise —, Comparison unavailable. Q3 2023, reported Aug 30, 2023: actual 0.053, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Mar 28, 2024: actual 0.051, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 30, 2024: actual 0.049, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 28, 2025: actual 0.004, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 29, 2025: actual 0.014, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 31, 2026: actual 0.023, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates828.14M568.34M308.55M48.75MQ3 '22BeatQ1 '23BeatQ3 '23BeatQ1 '24BeatQ3 '24BeatQ1 '25No estimateQ3 '25No estimateQ1 '26No estimate
Q3 2022, reported Aug 30, 2022: actual 650.35M HKD, estimate 60.26M HKD, surprise +979.30%, Beat. Q1 2023, reported Mar 29, 2023: actual 617.4M HKD, estimate 60.56M HKD, surprise +919.56%, Beat. Q3 2023, reported Aug 30, 2023: actual 691.09M HKD, estimate 57.36M HKD, surprise +1104.90%, Beat. Q1 2024, reported Mar 28, 2024: actual 730.22M HKD, estimate 57.39M HKD, surprise +1172.28%, Beat. Q3 2024, reported Aug 30, 2024: actual 701.42M HKD, estimate 58.31M HKD, surprise +1102.84%, Beat. Q1 2025, reported Mar 28, 2025: actual 692.39M HKD, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 29, 2025: actual 741.53M HKD, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 31, 2026: actual 771.04M HKD, estimate —, surprise —, Comparison unavailable.

ETFs holding 1302.HK

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Total International Stock ETF logoVanguard Total International Stock ETFVXUS
Market value
9.9M
Weight
0.00%
AUM
646.2B USD
Expense ratio
0.05%
Price / 1D
$87.20-0.58%
Vanguard FTSE Emerging Markets ETF logoVanguard FTSE Emerging Markets ETFVWO
Market value
9.58M
Weight
0.01%
AUM
162.3B USD
Expense ratio
0.06%
Price / 1D
$59.97-0.79%
iShares Core MSCI Emerging Markets ETF logoiShares Core MSCI Emerging Markets ETFIEMG
Market value
7.38M
Weight
0.00%
AUM
158.05B USD
Expense ratio
0.09%
Price / 1D
$80.49-1.32%
Vanguard FTSE All-World ex-US Small-Cap ETF logoVanguard FTSE All-World ex-US Small-Cap ETFVSS
Market value
2.87M
Weight
0.02%
AUM
13.6B USD
Expense ratio
0.06%
Price / 1D
$158.95-0.69%
iShares Core MSCI Total International Stock ETF logoiShares Core MSCI Total International Stock ETFIXUS
Market value
1.45M
Weight
0.00%
AUM
60.91B USD
Expense ratio
0.07%
Price / 1D
$97.40-0.56%
Avantis Emerging Markets Equity ETF logoAvantis Emerging Markets Equity ETFAVEM
Market value
1.28M
Weight
—
AUM
27.89B USD
Expense ratio
0.33%
Price / 1D
$93.11-1.20%
State Street SPDR Portfolio Emerging Markets ETF logoState Street SPDR Portfolio Emerging Markets ETFSPEM
Market value
1.06M
Weight
0.01%
AUM
17.74B USD
Expense ratio
0.07%
Price / 1D
$52.00-0.73%
Avantis Emerging Markets Value ETF logoAvantis Emerging Markets Value ETFAVES
Market value
730.25K
Weight
0.05%
AUM
1.5B USD
Expense ratio
0.36%
Price / 1D
$65.04-0.18%

Continue in GoAI

Research 1302.HK

research.disclaimer